Theraclion SA (TCLIF)
OTCMKTS · Delayed Price · Currency is USD
0.3200
+0.3198 (159,900.00%)
At close: Aug 26, 2024
Theraclion Market Cap
Theraclion has a market cap or net worth of $33.21 million as of October 17, 2025. Its market cap has increased by 60.12% in one year.
Market Cap
33.21M
Enterprise Value
37.19M
Revenue
859.52K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.32
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 51.93M to 33.21M, a decrease of -36.05%. That is a compound annual growth rate of -3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 34.22M | 116.93% |
| Dec 31, 2024 | 15.77M | -16.95% |
| Dec 29, 2023 | 18.99M | -32.03% |
| Dec 30, 2022 | 27.94M | -17.58% |
| Dec 31, 2021 | 33.90M | -10.02% |
| Dec 31, 2020 | 37.68M | 36.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 702.42M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.25M |